<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00708786</url>
  </required_header>
  <id_info>
    <org_study_id>ITAC01-VISION</org_study_id>
    <nct_id>NCT00708786</nct_id>
  </id_info>
  <brief_title>Ventricular Arrhythmias Incidence According to Sleep Apnea Syndrome in Implantable Cardioverter-Defibrillator (ICD) Patients</brief_title>
  <official_title>Ventricular Arrhythmias Incidence According to Sleep Apnea Syndrome in ICD Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>LivaNova</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>LivaNova</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to report the incidence of ventricular arrhythmias correlated to
      the SAS and to focus on the interest of diagnosing Sleep-disorders breathing in ICD patients.
      This diagnosis will be assessed by an ambulatory nasal pressure recording with portable
      multi-channel recorder associated to a complete SAS related symptoms questionnaire.This
      clinical trial will be the first step to gather information about the suspected sleep
      relation between ventricular arrhythmias and Sleep breathing disorders, in order to improve
      the management and treatment of such arrhythmias in next generation of defibrillators which
      will integrate a minute ventilation sensor able to monitor breathing.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2004</start_date>
  <completion_date type="Actual">October 2007</completion_date>
  <primary_completion_date type="Actual">October 2007</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The primary objective of this study is to assess the correlation between ventricular arrhythmias and Sleep apnoea syndrome in ICD patients during a 12-month follow-up.</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>To determine the number of arrhythmias in the morning (between 06:00 and 12:00 AM). The circadian distribution of global arrhythmias will be presented.</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To report and compare the number of hospitalizations, mortality, and morbidity according to Respiratory Disturbance Index (RDI).</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To evaluate the incidence of adverse events in the studied population: device-related adverse events with an actual or potential effect on the patient, serious adverse events not related to the device, mortality, and unanticipated adverse device effects</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">755</enrollment>
  <condition>Sleep Apnoea</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ICD</intervention_name>
    <description>Ventricular arrhythmia treatment</description>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CRT-D</intervention_name>
    <description>Ventricular arrhythmia treatment</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who are at risk of sudden death due to ventricular arrhythmia and who satisfy
             at least one of the following criteria are eligible for enrolment:

          -  Class I indications for ICD

               -  Survival of at least one episode of cardiac arrest due to VT or VF not due to a
                  transient or reversible cause, or presumed to be due to VF when
                  electrophysiological testing is precluded by other medical conditions; or

               -  Spontaneous sustained ventricular tachycardia, or

               -  Syncope of undetermined origin with clinically relevant haemodynamically
                  significant sustained VT or VF induced at electrophysiological study when drug
                  therapy is ineffective, not tolerated or not preferred, or

          -  Class IIa Indication for ICD

               -  Non-sustained VT with coronary disease, prior myocardial infarction, left
                  ventricular dysfunction (≤ 40%) and inducible VF or sustained VT at
                  electrophysiological study.

               -  With prior myocardial infarction and LVEF less than 30 % (without prior
                  life-threatening arrhythmia or sustained VT).

          -  Patients candidate for cardiac resynchronization therapy (CRT) need to be in
             functional Class III or IV of the NYHA classification.

        Patients will be included only after having granted their informed consent to participate
        in the study, preceded by the delivery of appropriate information

        Exclusion Criteria:

          -  VT/VF is associated with drug toxicity, electrolyte imbalance, hypoxia, electrocution
             or other reversible cause;

          -  VT/VF occurred during the acute phase of infarction (&lt; 1 week) or during an unstable
             ischemic phase;

          -  Incessant VT/VF;

          -  Implanted pacemaker that is not going to be explanted or otherwise disabled;

          -  Inability or refusal to provided informed consent

          -  Tricuspid valvular disease or tricuspid mechanical heart valve (lead
             contraindication);

          -  Unable to understand the purpose and plan of the study;

          -  Geographically unstable or not available for follow-up as defined in the
             investigational plan;

          -  Reduced life expectancy (≤ 1 year) for other than cardiovascular reasons;

          -  Patient participating in another clinical study;

          -  Patient of minor age (&lt; 18 years);

          -  Pregnancy (Women of childbearing potential are required to have a negative pregnancy
             test within seven days prior to enrollment).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Frédéric Anselme, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Charles Nicolle - Rouen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHRU Hopital de la cavale blanche</name>
      <address>
        <city>Brest</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU</name>
      <address>
        <city>Clermont Ferrand</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU - Hopital Michallon</name>
      <address>
        <city>Grenoble</city>
        <zip>38043</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Dupuytren</name>
      <address>
        <city>Limoges</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hopital cardiologique</name>
      <address>
        <city>Lyon</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hopital Saint Joseph et saint Luc</name>
      <address>
        <city>Lyon</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hopital Nord</name>
      <address>
        <city>Marseille</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHR Notre Dame de Bonsecours</name>
      <address>
        <city>Metz</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CH Montpellier</name>
      <address>
        <city>Montpellier</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nouvelle Clinique Nantaise</name>
      <address>
        <city>Nantes</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique Bizet</name>
      <address>
        <city>Paris cedex 16</city>
        <zip>75116</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique Bizet</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CH Pau</name>
      <address>
        <city>Pau</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Hopital la Milétrie</name>
      <address>
        <city>Poitiers</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHR Cardiologie A</name>
      <address>
        <city>Rennes</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Charles Nicolle</name>
      <address>
        <city>Rouen</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique Pasteur</name>
      <address>
        <city>Toulouse</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHRU Hopital Trousseau</name>
      <address>
        <city>Tours</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique Saint gatien</name>
      <address>
        <city>Tours</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHRU Brabois</name>
      <address>
        <city>Vandoeuvre les Nancy</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Herz-Kreislauf-Klinik Bevensen AG</name>
      <address>
        <city>Bad Bevensen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitatsklinikum Hamburg Eppendorf</name>
      <address>
        <city>Hamburg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Prof. Frey Praxis Starnberg</name>
      <address>
        <city>Starnberg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Onassis Cardiac Surgery Center</name>
      <address>
        <city>Athens</city>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Mellini</name>
      <address>
        <city>Chiari (BS)</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Osp. Civile</name>
      <address>
        <city>Desio</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Casa di Cura Montevergine</name>
      <address>
        <city>Mercogliano</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Policlinico de Modenna</name>
      <address>
        <city>Modenna</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Instituto di Cura</name>
      <address>
        <city>Pavia</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospitale civile Guglielmo da Saliceto</name>
      <address>
        <city>Piacenza</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Policlinico San Donato</name>
      <address>
        <city>San Donato</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
    <country>Germany</country>
    <country>Greece</country>
    <country>Italy</country>
  </location_countries>
  <verification_date>June 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 7, 2008</study_first_submitted>
  <study_first_submitted_qc>June 30, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 2, 2008</study_first_posted>
  <last_update_submitted>June 30, 2008</last_update_submitted>
  <last_update_submitted_qc>June 30, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 2, 2008</last_update_posted>
  <responsible_party>
    <name_title>F. Anselme - Principal investigator</name_title>
    <organization>CHRU Charles Nicolle</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

